242 filings
Page 4 of 13
8-K
79rkmdidzbv8ep77
23 Feb 11
K-V Pharmaceutical Company Announces Completion of a $32 Million
12:00am
8-K
fpauy9viooy5lnbvg1j
22 Feb 11
K-V Pharmaceutical Company Announces Completion of a $32 Million
12:00am
8-K
jdz2y7
16 Feb 11
Entry into a Material Definitive Agreement
12:00am
8-K
65deqol62t9ygbux5gww
15 Feb 11
Entry into a Material Definitive Agreement
12:00am
8-K
s0cjg5
15 Feb 11
This document contains various forward-looking statements within the meaning of the United States Litigation
12:00am
8-K
pponki14s
8 Feb 11
Entry into a Material Definitive Agreement
12:00am
8-K
iycsi6ojp2c kq
14 Jan 11
Other Events
12:00am
8-K
am5kh9 dy3w
22 Nov 10
Entry into a Material Definitive Agreement
12:00am
8-K
23pa02oolcaqk6
17 Nov 10
K-V Pharmaceutical Secures Financing Commitments Establishing Path Forward for Specialty Pharmaceutical Business
12:00am
8-K
0psdiop
5 Nov 10
Entry into a Material Definitive Agreement
12:00am
8-K
duow65d0d5j ka2416d1
28 Oct 10
Entry into a Material Definitive Agreement
12:00am
8-K
9cl2j80md045ofur
18 Oct 10
Entry into a Material Definitive Agreement
12:00am
8-K
wa7ug3f0q1b 57g
30 Sep 10
Entry into a Material Definitive Agreement
12:00am
8-K
za5bi3es86zu03j84q
17 Sep 10
K-V Pharmaceutical Company Secures $20 Million Loan
12:00am
8-K
v2tm8e3o0ocuca0a
10 Sep 10
Regulation FD Disclosure
12:00am
8-K
j9750puyd
8 Sep 10
K-V Pharmaceutical Company Receives Notification from
12:00am
8-K
wvaqdhx2z21l 6mn
13 Aug 10
K-V Pharmaceutical Company Announces the Election of
12:00am
8-K
n01yvqz6jqynnn7
9 Aug 10
Changes in Registrant's Certifying Accountant
12:00am
8-K
de5 0f4mpdrn
2 Aug 10
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am
8-K
0o39q3rr fp6qfponn
20 Jul 10
K-V Pharmaceutical Announces Resubmission to
12:00am